These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6622502)

  • 21. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations.
    Karttunen P; Tukiainen H; Nykänen S; Saano V
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative study of the pharmacokinetics and urinary metabolites of sustained-release theophylline syrup, granule and tablet preparations].
    Horiuchi Y; Takemura T; Ueno K
    Arerugi; 1991 Sep; 40(9):1186-93. PubMed ID: 1958133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers.
    Hollmann M; Müller-Peltzer H; Greger G; Brode E; Perucca E; Grimaldi R; Crema A
    Pharmacopsychiatry; 1987 Mar; 20(2):72-7. PubMed ID: 3588663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the effect of different kinds of foods on the bioavailability of a sustained-release theophylline tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):547-52. PubMed ID: 8294167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the pharmacokinetics of theophylline and its effect on respiratory impedance in asthmatic patients after multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Nosaka H; Satake T; Hasegawa T; Ogura Y; Mizukami Y
    Arerugi; 1986 May; 35(5):320-8. PubMed ID: 3753206
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
    Mellstrand T; Svedmyr K; Svedmyr N
    Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic comparison of a slow-release theophylline-hydroxyzine combination and a plain slow-release theophylline preparation.
    Tukiainen H; Silvasti M; Karttunen P; Savolainen K; Kokkonen P; Parviainen M
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):346-50. PubMed ID: 3209282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers.
    Talseth T; Boye NP; Bredesen JE; Kornstad S
    Ann Allergy; 1981 May; 46(5):279-80. PubMed ID: 7235323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of naproxen after oral administration of two tablet formulations in healthy volunteers.
    Aarbakke J; Gadeholt G; Høylandskjaer A
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):281-3. PubMed ID: 6885201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.